The ALS Treatment Market is expected to be around US$ 996 Million by 2028 at a CAGR of 6.15% in the given forecast period.
Amyotrophic lateral sclerosis is a neurodegenerative disorder. It is the greatest common category of motor neuron disease. Amyotrophic lateral sclerosis is a collection of rare neurological disorders that mainlycontain nerve cells responsible for monitoring voluntary muscle movement. Amyotrophic lateral sclerosis is also known as Lou Gehrig’s disease. The disease affects the action of motor neurons which results in the blockage of messages between brain fibers andmuscle. Amyotrophic lateral sclerosis can occur in aseparate due to mutation in gene which encrypts enzyme copper-zinc superoxide dismutase associated with defect in chromosome 9 and genetic inheritance. Amyotrophic lateral sclerosis disease is more prevalent in men. These deviations caused by genetic inheritance and mutations result in the publication of glutamate, which damages the motor neurons monitoringvolunteer muscles. The common symptoms of ALS contain muscles weakness, spasticity, cramps, respiratory problems, and fasciculation. Amyotrophic lateral sclerosis results in the incapability to respire. This is due to non-functioning of diaphragm and chest muscles caused due to muscle weakness.
The global ALS Treatment market is segregated on the basis of Treatment Outlook as Medication, Stem Cell Therapy, and Others. Based on Distribution Channel Outlook the global ALS Treatment market is segmented in Hospital Pharmacies, Retail Pharmacies, and Others.
The global ALS Treatment market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The ALS Treatment market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Rivalry
Mitsubishi Tanabe Pharma Corporation, Otsuka Pharmaceutical Co., Ltd., BrainStorm Therapeutics, Biogen Inc., Corestem, AB Science, F.Hoffmann-La Roche AG, Biohaven Pharmaceutical, Sun Pharmaceutical, Ionis Pharmaceuticals, Inc., and others are among the major players in the global ALS Treatment market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The ALS Treatment Market has been segmented as below:
ALS Treatment Market, By Treatment Outlook
ALS Treatment Market, By Distribution Channel Outlook
ALS Treatment Market, By Region
ALS Treatment Market, By Company
The report covers:
Report Scope:
The global ALS Treatment market report scope includes detailed study covering underlying factors influencing the industry trends. The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies. The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global ALS Treatment market share. Major industry players with significant revenue share include Mitsubishi Tanabe Pharma Corporation, Otsuka Pharmaceutical Co., Ltd., BrainStorm Therapeutics, Biogen Inc., Corestem, AB Science, F.Hoffmann-La Roche AG, Biohaven Pharmaceutical, Sun Pharmaceutical, Ionis Pharmaceuticals, Inc., and others.
Reasons to Buy this Report:
Customization
Customized report as per the requirement can be offered with appropriate recommendations.
Below are our New Reports :-
Clopidol (CAS 2971-90-6) Market
Robotic Pharmacy Prescription Dispensing Systems Market
Medical non-woven disposable market
1. Introduction
1.1. Key Points
1.2. Report Description
1.3. Markets Covered
1.4. Stakeholders
2. Research Methodology
2.1. Research Scope
2.2. Research Methodology
2.2.1. Market Research Process
2.2.2. Research Methodology
2.2.2.1. Secondary Research
2.2.2.2. Primary Research
2.2.2.3. Models for Estimation
2.3. Market Size Estimation
2.3.1. Bottom-Up Approach
2.3.2. Top-Down Approach
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Drivers
4.3. Restraints
4.4. Opportunities
4.5. Challenges
5. ALS Treatment Market, By Treatment Outlook
5.1. Key Points
5.2. Medication
5.3. Stem Cell Therapy
5.4. Others
6. ALS Treatment Market, By Distribution Channel Outlook
6.1. Key Points
6.2. Hospital Pharmacies
6.3. Retail Pharmacies
6.4. Others
7. Competitive Landscape
7.1. Introduction
7.2. Recent Developments
7.2.1. Mergers & Acquisitions
7.2.2. New Product Developments
7.2.3. Portfolio/Production Capacity Expansions
7.2.4. Joint Ventures, Collaborations, Partnerships & Agreements
7.2.5. Others
8. Company Profiles
8.1 Mitsubishi Tanabe Pharma Corporation
8.1.1 Company Overview
8.1.2 Product/Service Landscape
8.1.3 Financial Overview
8.1.4 Recent Developments
8.2 Otsuka Pharmaceutical Co., Ltd.
8.2.1 Company Overview
8.2.2 Product/Service Landscape
8.2.3 Financial Overview
8.2.4 Recent Developments
8.3 BrainStorm Therapeutics
8.3.1 Company Overview
8.3.2 Product/Service Landscape
8.3.3 Financial Overview
8.3.4 Recent Developments
8.4 Biogen Inc.
8.4.1 Company Overview
8.4.2 Product/Service Landscape
8.4.3 Financial Overview
8.4.4 Recent Developments
8.5 Corestem
8.5.1 Company Overview
8.5.2 Product/Service Landscape
8.5.3 Financial Overview
8.5.4 Recent Developments
8.6 AB Science
8.6.1 Company Overview
8.6.2 Product/Service Landscape
8.6.3 Financial Overview
8.6.4 Recent Developments
8.7 F.Hoffmann-La Roche AG
8.7.1 Company Overview
8.7.2 Product/Service Landscape
8.7.3 Financial Overview
8.7.4 Recent Developments
8.8 Biohaven Pharmaceutical
8.8.1 Company Overview
8.8.2 Product/Service Landscape
8.8.3 Financial Overview
8.8.4 Recent Developments
8.9 Sun Pharmaceutical
8.9.1 Company Overview
8.9.2 Product/Service Landscape
8.9.3 Financial Overview
8.9.4 Recent Developments
8.10 Ionis Pharmaceuticals, Inc.
8.10.1 Company Overview
8.10.2 Product/Service Landscape
8.10.3 Financial Overview
8.10.4 Recent Developments
The ALS Treatment Market has been segmented as below:
ALS Treatment Market, By Treatment Outlook
ALS Treatment Market, By Distribution Channel Outlook
ALS Treatment Market, By Region
ALS Treatment Market, By Company
